NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses

BACKGROUND: Therapeutic tumor vaccine (TTV) that induces tumor-specific immunity has enormous potentials in tumor treatment, but high heterogeneity and poor immunogenicity of tumor seriously impair its clinical efficacy. Herein, a novel NIR responsive tumor vaccine in situ (HA-PDA@IQ/DOX HG) was pre...

Full description

Saved in:
Bibliographic Details
Published in:J Nanobiotechnology
Main Authors: Zhang, Lirong, Zhang, Jingjing, Xu, Lixia, Zhuang, Zijian, Liu, Jingjin, Liu, Suwan, Wu, Yunchao, Gong, Aihua, Zhang, Miaomiao, Du, Fengyi
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8130144/
https://ncbi.nlm.nih.gov/pubmed/34001148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00880-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items